Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosusSchaper, F., de Leeuw, K., Horst, G., Maas, F., Bootsma, H., Heeringa, P., Limburg, P. C. & Westra, J., Jun-2017, In : Clinical and Experimental Immunology. 188, 3, p. 412-419 8 p.
Research output: Contribution to journal › Article › Academic › peer-review
Autoantibodies to nuclear structures are a hallmark of systemic lupus erythematosus (SLE), including autoantibodies to nuclear protein high mobility group box 1 (HMGB1). HMGB1 consists of three separate domains: box A, box B and an acidic tail. Recombinant box A acts as a competitive antagonist for HMGB1 and might be an interesting treatment option in SLE. However, antibodies to box A might interfere. Therefore, levels of anti-box A were examined in SLE patients in association with disease activity and clinical parameters. Serum anti-box A was measured in 86 SLE patients and 44 age- and sex-matched healthy controls (HC). Serum samples of 28 patients with primary Sjogren's syndrome and 32 patients with rheumatoid arthritis were included as disease controls. Anti-HMGB1 and anti-box B levels were also measured by enzyme-linked immunosorbent assay during quiescent disease [SLE Disease Activity Index (SLEDAI) = 5, n=39). Anti-box A levels in active SLE patients were higher compared to quiescent patients, and were increased significantly compared to HC and disease controls. Anti-box A levels correlated positively with SLEDAI and anti-dsDNA levels and negatively with complement C3 levels. Increased levels of anti-box A antibodies were present in the majority of patients with nephritic (73%) and non-nephritic exacerbations (71%). Antibodies to the box A domain of HMGB1 might be an interesting new biomarker, as these had a high specificity for SLE and were associated with disease activity. Longitudinal studies should be performed to evaluate whether these antibodies perform better in predicting an exacerbation, especially non-nephritic exacerbations.
|Number of pages||8|
|Journal||Clinical and Experimental Immunology|
|Early online date||9-May-2017|
|Publication status||Published - Jun-2017|
- anti-box A, anti-HMGB1, autoantibodies, HMGB1, SLE, CHROMOSOMAL-PROTEIN 1, DISEASE-ACTIVITY, ANTI-HMGB1 ANTIBODIES, CYTOKINE RELEASE, RECEPTOR 4, ARTHRITIS, MICE, NEPHRITIS, CLASSIFICATION